10 20 30 40 50 60 70 80 1JGD - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER IMMUNE SYSTEM 25-JUN-01 1JGD
TITLE HLA-B*2709 BOUND TO DECA-PEPTIDE S10R
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN LYMPHOCYTE ANTIGEN HLA-B27; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: PEPTIDE S10R; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-B OR HLAB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED.
KEYWDS MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE KEYWDS 2 ANTIGEN), IMMUNE SYSTEM
EXPDTA X-RAY DIFFRACTION
AUTHOR R.C.HILLIG,M.HUELSMEYER,W.SAENGER,A.VOLZ,B.UCHANSKA-ZIEGLER,A.ZIEGLER
REVDAT 5 13-JUL-11 1JGD 1 VERSN REVDAT 4 24-FEB-09 1JGD 1 VERSN REVDAT 3 13-JAN-04 1JGD 1 JRNL REMARK MASTER REVDAT 2 29-JUL-03 1JGD 1 JRNL REVDAT 1 01-JUL-03 1JGD 0
JRNL AUTH R.C.HILLIG,M.HUELSMEYER,W.SAENGER,K.WELFLE,R.MISSELWITZ, JRNL AUTH 2 H.WELFLE,KOZERSKI C.,A.VOLZ,B.UCHANSKA-ZIEGLER,A.ZIEGLER JRNL TITL THERMODYNAMIC AND STRUCTURAL ANALYSIS OF PEPTIDE- AND JRNL TITL 2 ALLELE-DEPENDENT PROPERTIES OF TWO HLA-B27 SUBTYPES JRNL TITL 3 EXHIBITING DIFFERENTIAL DISEASE ASSOCIATION JRNL REF J.BIOL.CHEM. V. 279 652 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 14555655 JRNL DOI 10.1074/JBC.M307457200
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.HULSMEYER,R.C.HILLIG,A.VOLZ,M.RUHL,W.SCHRODER,W.SAENGER, REMARK 1 AUTH 2 A.ZIEGLER,B.UCHANSKA-ZIEGLER REMARK 1 TITL HLA-B27 SUBTYPES DIFFERENTIALLY ASSOCIATED WITH DISEASE REMARK 1 TITL 2 EXHIBIT SUBTLE STRUCTURAL ALTERATIONS REMARK 1 REF J.BIOL.CHEM. V. 277 47844 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M206392200 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.DEL PORTO,M.D'AMATO,M.T.FIORILLO,L.TUOSTO,E.PICCOLELLA, REMARK 1 AUTH 2 R.SORRENTION REMARK 1 TITL IDENTIFICATION OF A NOVEL HLA-B27 SUBTYPE BY RESTRICTION REMARK 1 TITL 2 ANALYSIS OF A CYTOTOXIC GAMMA DELTA T CELL CLONE REMARK 1 REF J.IMMUNOL. V. 153 3093 1994 REMARK 1 REFN ISSN 0022-1767 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.R.MADDEN,J.C.GORGA,J.L.STROMINGER,D.C.WILEY REMARK 1 TITL THE STRUCTURE OF HLA-B27 REVEALS NONAMER SELF-PEPTIDES BOUND REMARK 1 TITL 2 IN AN EXTENDED CONFORMATION REMARK 1 REF NATURE V. 353 321 1991 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/353321A0 REMARK 1 REFERENCE 4 REMARK 1 AUTH D.R.MADDEN,J.C.GORGA,J.L.STROMINGER,D.C.WILEY REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 A REMARK 1 TITL 2 RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE REMARK 1 TITL 3 BINDING TO MHC REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 70 1035 1992 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/0092-8674(92)90252-8
REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 37162 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1905 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3184 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 452 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.44000 REMARK 3 B22 (A**2) : 0.82000 REMARK 3 B33 (A**2) : 0.26000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.45000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.017 ; 0.021 REMARK 3 ANGLE DISTANCE (A) : 1.872 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.984 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.629 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.862 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.618 ; 4.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1JGD COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-01. REMARK 100 THE RCSB ID CODE IS RCSB013738.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-AUG-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0500 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37162 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 14.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 28.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.38600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1JGE REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, TRIS-HCL, NACL; GLYCEROL AS REMARK 280 CRYO PROTECTANT, PH 8.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.92200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.21900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.92200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.21900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HETEROTRIMERIC COMPLEX REMARK 300 CONSISTING OF ONE HLA-B*2709 (HEAVY) CHAIN, ONE BETA-2- REMARK 300 MICROGLOBULIN (LIGHT) CHAIN AND ONE DECAMERIC MODEL PEPTIDE S10R.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 119 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 227 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP B 76 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG C 1 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 15 -89.83 -24.92 REMARK 500 ARG A 17 30.24 -151.48 REMARK 500 ASP A 29 -127.45 49.44 REMARK 500 ALA A 41 -73.46 -39.38 REMARK 500 HIS A 114 109.82 -165.38 REMARK 500 SER A 131 -1.82 -142.15 REMARK 500 ARG A 239 -4.75 82.09 REMARK 500 LYS B 48 57.76 -94.80 REMARK 500 TRP B 60 -8.10 79.72 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 555 DISTANCE = 5.60 ANGSTROMS REMARK 525 HOH A 807 DISTANCE = 5.20 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 500
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HLA-B*2705 IN COMPLEX WITH AN ENDOGENOUS MIXTURE OF REMARK 900 NONAMERIC PEPTIDES REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 IN COMPLEX WITH NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 IN COMPLEX WITH NONA-PEPTIDE M9
DBREF 1JGD A 1 276 UNP P03989 1B27_HUMAN 25 300 DBREF 1JGD B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 1JGD C 1 10 PDB 1JGD 1JGD 1 10
SEQADV 1JGD MET B 0 UNP P61769 CLONING ARTIFACT
SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE HIS THR SER VAL SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE THR VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR LEU PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER PRO ARG GLU GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP ARG GLU THR GLN SEQRES 6 A 276 ILE CYS LYS ALA LYS ALA GLN THR ASP ARG GLU ASP LEU SEQRES 7 A 276 ARG THR LEU LEU ARG TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS THR LEU GLN ASN MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 PRO ASP GLY ARG LEU LEU ARG GLY TYR HIS GLN HIS ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 276 SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE THR SEQRES 12 A 276 GLN ARG LYS TRP GLU ALA ALA ARG VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY GLU CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG ALA SEQRES 15 A 276 ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO ILE SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 10 ARG ARG LEU LEU ARG GLY HIS ASN GLN TYR
HET GOL A 500 6
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *452(H2 O)
HELIX 1 1 ARG A 14 GLY A 18 5 5 HELIX 2 2 ALA A 49 GLN A 54 1 6 HELIX 3 3 GLY A 56 TYR A 85 1 30 HELIX 4 4 ASP A 137 ALA A 150 1 14 HELIX 5 5 ARG A 151 GLY A 162 1 12 HELIX 6 6 GLY A 162 GLY A 175 1 14 HELIX 7 7 GLY A 175 GLN A 180 1 6 HELIX 8 8 THR A 225 THR A 228 5 4 HELIX 9 9 GLU A 253 GLN A 255 5 3
SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N THR A 24 O PHE A 36 SHEET 4 A 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 A 8 THR A 94 VAL A 103 -1 N LEU A 95 O SER A 11 SHEET 6 A 8 LEU A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 A 8 TRP A 133 ALA A 135 -1 N THR A 134 O ALA A 125 SHEET 1 B 4 LYS A 186 PRO A 193 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 B 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 B 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 PRO A 193 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 C 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 4 GLU A 222 ASP A 223 0 SHEET 2 D 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 D 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 D 4 LEU A 270 LEU A 272 -1 N LEU A 270 O VAL A 261 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 E 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 F 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 F 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 G 4 GLU B 44 ARG B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 G 4 LYS B 91 LYS B 94 -1 N LYS B 91 O VAL B 82
SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.14 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.01 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.02
CISPEP 1 TYR A 209 PRO A 210 0 2.42 CISPEP 2 HIS B 31 PRO B 32 0 2.24
SITE 1 AC1 7 THR A 31 THR A 178 LEU A 179 ARG A 181 SITE 2 AC1 7 ASP A 183 TYR A 209 HOH A 638
CRYST1 129.844 48.438 88.532 90.00 121.29 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007702 0.000000 0.004681 0.00000
SCALE2 0.000000 0.020645 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013218 0.00000